These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34744974)

  • 61. Sex modifies APOE ε4 dose effect on brain tau deposition in cognitively impaired individuals.
    Yan S; Zheng C; Paranjpe MD; Li Y; Li W; Wang X; Benzinger TLS; Lu J; Zhou Y
    Brain; 2021 Nov; 144(10):3201-3211. PubMed ID: 33876815
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Education halves the risk of dementia due to apolipoprotein ε4 allele: a collaborative study from the Swedish brain power initiative.
    Wang HX; Gustafson DR; Kivipelto M; Pedersen NL; Skoog I; Windblad B; Fratiglioni L
    Neurobiol Aging; 2012 May; 33(5):1007.e1-7. PubMed ID: 22056199
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Apolipoprotein E ε4 genotype and the temporal relationship between depression and dementia.
    Karlsson IK; Bennet AM; Ploner A; Andersson TM; Reynolds CA; Gatz M; Pedersen NL
    Neurobiol Aging; 2015 Apr; 36(4):1751-1756. PubMed ID: 25670333
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset.
    Hirono N; Hashimoto M; Yasuda M; Ishii K; Sakamoto S; Kazui H; Mori E
    Neurology; 2002 Mar; 58(5):743-50. PubMed ID: 11889238
    [TBL] [Abstract][Full Text] [Related]  

  • 66. APOE ε4 Carriers Have a Greater Propensity to Glycation and sRAGE Which Is Further Influenced by RAGE G82S Polymorphism.
    Deo P; Dhillon VS; Chua A; Thomas P; Fenech M
    J Gerontol A Biol Sci Med Sci; 2020 Sep; 75(10):1899-1905. PubMed ID: 31677348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Apolipoprotein E epsilon-4 polymorphism is associated with younger age at referral to a lipidology clinic and a poorer response to lipid-lowering therapy.
    Baptista R; Rebelo M; Decq-Mota J; Dias P; Monteiro P; Providência LA; Silva JM
    Lipids Health Dis; 2011 Mar; 10():48. PubMed ID: 21450082
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Apolipoprotein E Genotype and Sex Risk Factors for Alzheimer Disease: A Meta-analysis.
    Neu SC; Pa J; Kukull W; Beekly D; Kuzma A; Gangadharan P; Wang LS; Romero K; Arneric SP; Redolfi A; Orlandi D; Frisoni GB; Au R; Devine S; Auerbach S; Espinosa A; Boada M; Ruiz A; Johnson SC; Koscik R; Wang JJ; Hsu WC; Chen YL; Toga AW
    JAMA Neurol; 2017 Oct; 74(10):1178-1189. PubMed ID: 28846757
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Apolipoprotein E epsilon4 allele and familial aggregation of Alzheimer disease.
    Martinez M; Campion D; Brice A; Hannequin D; Dubois B; Didierjean O; Michon A; Thomas-Anterion C; Puel M; Frebourg T; Agid Y; Clerget-Darpoux F
    Arch Neurol; 1998 Jun; 55(6):810-6. PubMed ID: 9626772
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Revisiting the Role of Insulin-Like Growth Factor-I Receptor Stimulating Activity and the Apolipoprotein E in Alzheimer's Disease.
    Galle SA; van der Spek A; Drent ML; Brugts MP; Scherder EJA; Janssen JAMJL; Ikram MA; van Duijn CM
    Front Aging Neurosci; 2019; 11():20. PubMed ID: 30809143
    [No Abstract]   [Full Text] [Related]  

  • 71. Predictive value of APOE-ε4 allele for progression from MCI to AD-type dementia: a meta-analysis.
    Elias-Sonnenschein LS; Viechtbauer W; Ramakers IH; Verhey FR; Visser PJ
    J Neurol Neurosurg Psychiatry; 2011 Oct; 82(10):1149-56. PubMed ID: 21493755
    [TBL] [Abstract][Full Text] [Related]  

  • 72. APOE-ε4 Genotype and Dementia Before and After Transient Ischemic Attack and Stroke: Population-Based Cohort Study.
    Pendlebury ST; Poole D; Burgess A; Duerden J; Rothwell PM;
    Stroke; 2020 Mar; 51(3):751-758. PubMed ID: 32070224
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Longitudinal change in working memory as a function of APOE genotype in midlife and old age.
    Greenwood PM; Espeseth T; Lin MK; Reinvang I; Parasuraman R
    Scand J Psychol; 2014 Jun; 55(3):268-77. PubMed ID: 24853824
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Differential associations of APOE-ε2 and APOE-ε4 alleles with PET-measured amyloid-β and tau deposition in older individuals without dementia.
    Salvadó G; Grothe MJ; Groot C; Moscoso A; Schöll M; Gispert JD; Ossenkoppele R;
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(7):2212-2224. PubMed ID: 33521872
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relationship between the Presence of the
    Gutiérrez-de Pablo V; Gómez C; Poza J; Maturana-Candelas A; Martins S; Gomes I; Lopes AM; Pinto N; Hornero R
    Sensors (Basel); 2020 Jul; 20(14):. PubMed ID: 32664228
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
    Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
    Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Association between APOE epsilon4 allele and vascular dementia: The Cache County study.
    Chuang YF; Hayden KM; Norton MC; Tschanz J; Breitner JC; Welsh-Bohmer KA; Zandi PP
    Dement Geriatr Cogn Disord; 2010; 29(3):248-53. PubMed ID: 20375505
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
    Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
    Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The apolipoprotein E epsilon4 allele and memory performance in HIV-1 seropositive subjects: differences at baseline but not after acute oral lorazepam challenge.
    Pomara N; Belzer KD; Silva R; Cooper TB; Sidtis JJ
    Psychopharmacology (Berl); 2008 Nov; 201(1):125-35. PubMed ID: 18668226
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    Weintraub S; Teylan M; Rader B; Chan KCG; Bollenbeck M; Kukull WA; Coventry C; Rogalski E; Bigio E; Mesulam MM
    Neurology; 2020 Feb; 94(6):e607-e612. PubMed ID: 31704790
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.